Rebiotix Overview
- Year Founded
-
2011
- Status
-
Acquired/Merged
- Employees
-
65
- Latest Deal Type
-
2ndary - Private
- Latest Deal Amount
-
$700K
Rebiotix General Information
Description
Developer of human microbe drugs designed for the treatment of gastrointestinal diseases. The company's drug represents a new approach to the treatment of diseases by delivering live, human-derived microbes into a sick patient's intestinal tract, enabling healthcare providers to cure challenging diseases and recurrent infections.
Contact Information
Website
www.rebiotix.comCorporate Office
- 2660 Patton Road
- Roseville, MN 55113
- United States
Corporate Office
- 2660 Patton Road
- Roseville, MN 55113
- United States
Rebiotix Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Secondary Transaction - Private | 22-Dec-2022 | $700K | Completed | Clinical Trials - Phase 3 | ||
| 7. Merger/Acquisition | 05-Apr-2018 | Completed | Clinical Trials - Phase 3 | |||
| 6. Later Stage VC | 05-Sep-2017 | Completed | Clinical Trials - Phase 3 | |||
| 5. Later Stage VC | Completed | Clinical Trials - Phase 3 | ||||
| 4. Early Stage VC (Series B) | 04-Aug-2014 | Completed | Product Development | |||
| 3. Accelerator/Incubator | 01-Jan-2013 | Completed | Startup | |||
| 2. Early Stage VC (Series A) | 15-Dec-2011 | $5M | Completed | Startup | ||
| 1. Early Stage VC (Series 1) | 04-Nov-2011 | $5M | $5M | Completed | Startup |
Rebiotix Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series 2 | ||||||||
| Series 1 |
Rebiotix Comparisons
Industry
Financing
Details
Rebiotix Competitors (66)
One of Rebiotix’s 66 competitors is Venatorx Pharmaceuticals, a Venture Capital-Backed company based in Malvern, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Venatorx Pharmaceuticals | Venture Capital-Backed | Malvern, PA | ||||
| NovaBiotics | Venture Capital-Backed | Aberdeen, United Kingdom | ||||
| OrphoMed | Venture Capital-Backed | San Francisco, CA | ||||
| Enterome | Venture Capital-Backed | Paris, France | ||||
| Emerald Health Pharmaceuticals | Venture Capital-Backed | San Diego, CA |
Rebiotix Patents
Rebiotix Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025054086-A1 | Microbiota restoration therapy (mrt) compositions and methods of administration | Inactive | 06-Sep-2023 | ||
| WO-2019241523-A1 | Microbiota restoration therapy (mrt) compositions and methods of manufacture | Inactive | 14-Jun-2018 | ||
| AU-2018347619-A1 | Microbiome health index | Inactive | 13-Oct-2017 | ||
| CA-3076359-A1 | Microbiome health index | Inactive | 13-Oct-2017 | ||
| EP-3695017-A1 | Microbiome health index | Inactive | 13-Oct-2017 | C12Q1/689 |
Rebiotix Signals
Rebiotix Former Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Aspen Venture | Venture Capital | Minority | ||
| JVC Investment Partners | Family Office | Minority | ||
| Lateral Capital Management | Venture Capital | Minority | ||
| Sofia Fund | Angel Group | Minority | ||
| Springboard Enterprises | Accelerator/Incubator | Minority |
Rebiotix FAQs
-
When was Rebiotix founded?
Rebiotix was founded in 2011.
-
Where is Rebiotix headquartered?
Rebiotix is headquartered in Roseville, MN.
-
What is the size of Rebiotix?
Rebiotix has 65 total employees.
-
What industry is Rebiotix in?
Rebiotix’s primary industry is Drug Discovery.
-
Is Rebiotix a private or public company?
Rebiotix is a Private company.
-
What is Rebiotix’s current revenue?
The current revenue for Rebiotix is .
-
How much funding has Rebiotix raised over time?
Rebiotix has raised $38.5M.
-
Who are Rebiotix’s investors?
Aspen Venture, JVC Investment Partners, Lateral Capital Management, Sofia Fund, and Springboard Enterprises are 5 of 6 investors who have invested in Rebiotix.
-
Who are Rebiotix’s competitors?
Venatorx Pharmaceuticals, NovaBiotics, OrphoMed, Enterome, and Emerald Health Pharmaceuticals are some of the 66 competitors of Rebiotix.
-
When was Rebiotix acquired?
Rebiotix was acquired on 22-Dec-2022.
-
Who acquired Rebiotix?
Rebiotix was acquired by Ferring.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process